Last filing: Jul 27, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Quest Diagnostics (DGX) | Executive Vice President & CFO | Jul 26, 2022 | Jul 27, 2026 |
| Idexx Laboratories (IDXX) | Director | Jul 18, 2019 | May 14, 2026 |
| Illumina, Inc. (ILMN) | Former SVP and CFO | Jan 12, 2017 | Mar 3, 2022 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 22, 2026, Quest Diagnostics: 102 shares granted. 1 filing: 1
- Apr 20, 2026, Quest Diagnostics: 108 shares granted. 1 filing: 1
- Mar 4, 2026, Quest Diagnostics: 13,947 shares awarded; 7,720 shares withheld by the company for taxes. 1 filing: 1
- Mar 2, 2026, Quest Diagnostics: 869 shares withheld by the company for taxes. 1 filing: 1
- Feb 18, 2026, Quest Diagnostics: 3,965 shares granted; 1,865 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.